UCL Queen Square Institute of Neurology


UK Dementia Research Institute Director elected to the U.S. National Academy of Medicine

19 October 2022

Prof Bart De Strooper, UK Dementia Research Institute (UK DRI) Director, has been elected to the U.S. National Academy of Medicine (NAM), for his work in understanding the mechanisms of Alzheimer’s disease, ‘in an unrelenting search for therapeutic targets that can help patients’

Bart De Strooper

Professor De Strooper (UK DRI Director and Group Leader, UK Dementia Research Institute at UCL) is one of only 10 international researchers elected to the Academy this year, which recognises individuals who have demonstrated outstanding professional achievement and commitment to service.

New members are elected by current members through a process that recognises individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. The newly elected members bring NAM’s total membership to more than 2,200, including 190 international members.

Prof Bart De Strooper said: “I am delighted and honoured to be elected as a member of this prestigious organisation, and I look forward to helping the Academy advance towards its mission of improving health for all. “We have made great progress in the field of dementia discovery research in recent years, and I am hopeful that we are close to a breakthrough that will lead to effective treatments for these devastating diseases.”
National Academy of Medicine President Victor J. Dzau said:  “This extraordinary class of new members is comprised of exceptional scholars and leaders who have been at the forefront of responding to serious public health challenges, combatting social inequities, and achieving innovative discoveries. Their expertise will be vital to informing the future of health and medicine for the benefit of us all. I am truly honored to welcome these esteemed individuals to the National Academy of Medicine.”